Sickle Cell Disease: Market Trends, Epidemiology, and Forecast until 2034
“In 2023, the total Sickle Cell Disease market size was around USD 650 million . This figure is anticipated to grow by 2034 within the study period (2020–2034) across the 6MM.” Sickle Cell Disease is a genetic blood disorder characterized by the production of abnormal hemoglobin, leading to distorted, sickle-shaped red blood cells. These cells can obstruct blood flow, causing pain, organ damage, and increased risk of infection. SCD primarily affects individuals of African, Middle Eastern, and Indian ancestry. Sickle Cell Disease Market Insight Sickle Cell Disease (SCD) is a genetic blood disorder characterized by the production of abnormal hemoglobin, leading to the formation of rigid, sickle-shaped red blood cells. These misshapen cells can block blood flow, causing severe pain, organ damage, and increased risk of infection. The global market for Sickle Cell Disease treatments is witnessing substantial growth driven by advancements in gene therapy, increased awareness, and improved